News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
309,811 Results
Type
Article (15677)
Company Profile (284)
Press Release (293850)
Multimedia
Podcasts (59)
Webinars (9)
Section
Business (94122)
Career Advice (195)
Deals (15890)
Drug Delivery (48)
Drug Development (52334)
Employer Resources (39)
FDA (6489)
Job Trends (6719)
News (164390)
Policy (11165)
Tag
Academia (1001)
Accelerated approval (3)
Adcomms (16)
Allergies (68)
Alliances (24078)
ALS (77)
Alzheimer's disease (899)
Antibody-drug conjugate (ADC) (132)
Approvals (6518)
Artificial intelligence (171)
Autoimmune disease (24)
Automation (10)
Bankruptcy (114)
Best Places to Work (5395)
BIOSECURE Act (8)
Biosimilars (60)
Biotechnology (234)
Bladder cancer (68)
Brain cancer (27)
Breast cancer (212)
Cancer (1965)
Cardiovascular disease (160)
Career advice (168)
Career pathing (2)
CAR-T (160)
CDC (7)
Cell therapy (414)
Cervical cancer (10)
Clinical research (43065)
Collaboration (712)
Company closure (1)
Compensation (326)
Complete response letters (17)
COVID-19 (1122)
CRISPR (59)
C-suite (223)
Cystic fibrosis (90)
Data (2094)
Denatured (11)
Depression (42)
Diabetes (190)
Diagnostics (2031)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (102)
Drug pricing (42)
Drug shortages (5)
Duchenne muscular dystrophy (115)
Earnings (37010)
Editorial (19)
Employer branding (4)
Employer resources (36)
Events (52112)
Executive appointments (614)
FDA (7489)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (678)
Gene editing (121)
Generative AI (13)
Gene therapy (324)
GLP-1 (458)
Government (1248)
Grass and pollen (3)
Guidances (108)
Healthcare (7967)
Huntington's disease (30)
IgA nephropathy (37)
Immunology and inflammation (124)
Immuno-oncology (4)
Indications (29)
Infectious disease (1208)
Inflammatory bowel disease (125)
Inflation Reduction Act (9)
Influenza (26)
Intellectual property (82)
Interviews (22)
IPO (8450)
IRA (14)
Job creations (1619)
Job search strategy (159)
Kidney cancer (10)
Labor market (9)
Layoffs (237)
Leadership (4)
Legal (1559)
Liver cancer (37)
Lung cancer (279)
Lymphoma (149)
Machine learning (5)
Management (9)
Manufacturing (231)
MASH (76)
Medical device (3985)
Medtech (3987)
Mergers & acquisitions (7926)
Metabolic disorders (517)
Multiple sclerosis (66)
NASH (17)
Neurodegenerative disease (87)
Neuropsychiatric disorders (30)
Neuroscience (1409)
NextGen: Class of 2025 (2454)
Non-profit (1062)
Now hiring (25)
Obesity (248)
Opinion (112)
Ovarian cancer (86)
Pain (56)
Pancreatic cancer (82)
Parkinson's disease (152)
Partnered (8)
Patents (170)
Patient recruitment (109)
Peanut (38)
People (29622)
Pharmaceutical (49)
Pharmacy benefit managers (6)
Phase I (15422)
Phase II (19981)
Phase III (12598)
Pipeline (1193)
Policy (72)
Postmarket research (893)
Preclinical (6378)
Press Release (36)
Prostate cancer (89)
Psychedelics (37)
Radiopharmaceuticals (228)
Rare diseases (362)
Real estate (3177)
Recruiting (16)
Regulatory (9737)
Reports (22)
Research institute (1023)
Resumes & cover letters (24)
Rett syndrome (8)
RNA editing (9)
RSV (20)
Schizophrenia (70)
Series A (124)
Series B (85)
Service/supplier (1)
Sickle cell disease (47)
Special edition (13)
Spinal muscular atrophy (118)
Sponsored (16)
Startups (2143)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (25)
The Weekly (47)
Vaccines (283)
Venture capital (37)
Weight loss (137)
Women's health (18)
Worklife (2)
Date
Today (44)
Last 7 days (391)
Last 30 days (1584)
Last 365 days (20446)
2025 (10537)
2024 (22581)
2023 (24688)
2022 (31084)
2021 (32253)
2020 (26971)
2019 (19347)
2018 (14110)
2017 (15598)
2016 (13356)
2015 (16156)
2014 (11644)
2013 (8429)
2012 (8699)
2011 (8850)
2010 (8441)
Location
Africa (185)
Alabama (52)
Alaska (3)
Arizona (68)
Arkansas (7)
Asia (19900)
Australia (3345)
California (4975)
Canada (1413)
China (499)
Colorado (201)
Connecticut (183)
Delaware (136)
Europe (42591)
Florida (635)
Georgia (153)
Hawaii (1)
Idaho (23)
Illinois (339)
India (15)
Indiana (160)
Iowa (9)
Japan (130)
Kansas (67)
Kentucky (12)
Louisiana (9)
Maine (43)
Maryland (609)
Massachusetts (3897)
Michigan (117)
Minnesota (202)
Mississippi (3)
Missouri (34)
Montana (15)
Nebraska (6)
Nevada (30)
New Hampshire (39)
New Jersey (1235)
New Mexico (17)
New York (1346)
North Carolina (670)
North Dakota (6)
Northern California (2203)
Ohio (136)
Oklahoma (11)
Oregon (24)
Pennsylvania (936)
Puerto Rico (8)
Rhode Island (23)
South America (308)
South Carolina (15)
South Dakota (1)
Southern California (1895)
Tennessee (62)
Texas (615)
United States (17224)
Utah (82)
Virginia (104)
Washington D.C. (37)
Washington State (421)
West Virginia (3)
Wisconsin (29)
309,811 Results for "expansion therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lymphoma
Roche’s Genentech Fails to Win Adcomm Backing for Columvi Expansion
The ODAC cited concerns with patient populations in clinical trials used to support the proposed expansion. Johnson & Johnson fared better, with the FDA’s cancer advisors voting to recommend Darzalex in patients with a certain type of multiple myeloma.
May 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Javara Secures Series C Funding To Drive Therapeutic Expansion For Community-Forward Clinical Research
May 28, 2025
·
2 min read
Press Releases
RION names Biopharma Veteran Suneet Varma as Senior Advisor to Spearhead Expansion into Regenerative Therapeutics
May 1, 2025
·
2 min read
Press Releases
Marker Therapeutics Reports that Lymphodepletion Improves the Expansion and Persistence of Multi-Antigen Recognizing T Cells in Patients with Lymphoma
May 20, 2025
·
8 min read
FDA
J&J Wins Crohn’s Expansion for Tremfya as Stelara Biosimilars Enter US Market
The label expansion could help J&J establish Tremfya as a successor to Stelara, which is now facing a growing biosimilar challenge.
March 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Orogen Therapeutics Announces Expansion of Board with Biopharma Leaders Mikael Dolsten and Dieter Weinand as Independent Non-Executive Directors.
May 7, 2025
·
7 min read
Press Releases
Eterna Therapeutics Announces Expansion of Scientific Advisory Board
January 28, 2025
·
4 min read
Press Releases
Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates
May 5, 2025
·
7 min read
Approvals
AstraZeneca, Daiichi Sankyo Continue ADC Rally With Enhertu Expansion
Enhertu’s label expansion comes on the heels of the FDA’s approval of the partners’ Datroway for a related type of breast cancer.
January 28, 2025
·
2 min read
·
Tristan Manalac
BioMidwest
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia
DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia.
June 26, 2024
·
13 min read
1 of 30,982
Next
